14 August 2019

D CEO Healthcare: Avoiding Pre-Term Birth with Text Messages




D CEO Healthcare features PCCI’s work with the Parkland Community Health Plan and Parkland Hospital on pre-term birth prevention. The results of this work show how PCCI and Parkland are working together to develop innovative ways to improve healthcare for the under-served in our community.

##

Avoiding Pre-Term Birth with Text Messages in Dallas

At the Parkland Center for Clinical Innovation, data analytics and technology are improving outcomes for underserved pregnant women in Dallas. One significant way to reduce maternal and infant mortality is to avoid pre-term birth, and in 2017, Texas had a 10.4 percent pre-term birth rate – earning a D in the annual ranking from March of Dimes.

PCCI is a nonprofit that marries data science and social determinants of health to improve outcomes for  underserved populations in Dallas. In one of its initiatives, the group targeted 700 women at risk of pre-term birth, and engaged them with a series of text reminders about everything from general wellness and prescriptions to what to expect and pre-natal appointments. Avoiding pre-term birth is beneficial for the women and children, but for a hospital like Parkland where the majority of the care they provide is uncompensated, keeping mothers healthy and babies out of the NICU can significantly reduce costs.

The women were enrolled in the Parkland health plan, which reached out to them to get the women signed up for the texting system. Pre-term birth can be a difficult thing to predict, says Dr. Joseph Chang, Associate Chief Medical Officer for Outpatient and Ambulatory Services at Parkland. Traditionally, the only way to know if a women was going to have a pre-term birth was if she had a past pre-term birth. But he says that a couple of interventions, including progesterone shots, can make a huge difference.

“Adherence to medicine is the biggest factor,” Chang says. “If we really were able to identify the right people, use a platform for today’s young parents, maybe that would really work.”

Because Parkland is both the health plan and the healthcare provider, PCCI was able to access both sides of the payer relationship in a way that can be difficult to access in traditional healthcare systems. Their system brought the electronic health record together with behavioral health information to identify the women, and yielded impressive results.

Appointments were closely monitored, with PCCI measuring data along the way to adjust the text messaging and tailor it to the patients’ needs. After just one year, women in the program increased prenatal visit attendance by 24 percent, reduced pre-term birth by 27 percent. The program also reduced post-delivery cost by 54 percent in the first year.  The 679 women who enrolled saved the system $1 million in the first year.

Fighting healthcare battles before the patient arrives at the doctor is important for PCCI CEO Steve Miff. “Health begins where we work, live, learn, play, and pray,” he says. “We are moving upstream, because if they are not addressed it will have a negative impact on health.”

Politico covered PCCI’s efforts to reduce frequent flyers by targeting patients who lacked many of the supports needed after they left the hospital. Their software connected social service agencies to the healthcare system to refer patients to get those services outside of the hospital, which would be cheaper and more efficient than seeing patients return again and again because they lacked food or housing. The impact was significant. The pre-term birth program is another way to head off medical costs before they happen.

Looking ahead, PCCI hopes to continue to fight social isolation to provide access to services, improving many of the behavioral and environmental factors that negatively impact health. “How do we use digital tech and bring women together, create clusters of similar individuals, customize behavioral therapy?” Miff says. “We can do that via a digitally provided environment, we can do it from home, and bridge the gap via telemedicine.”

Chang sees this technology being applied to any number of ailments, but sees a massive opportunity in addressing diabetes treatment. There are apps for measuring and taking glucose, but the texting might be more effective because it doesn’t require another application. “The biggest problem is taking their medicine – taking it and taking it correctly.”

https://healthcare.dmagazine.com/2019/08/13/avoiding-pre-term-birth-with-text-messages-in-dallas/

5 August 2019

In The News: Mobile Health Times reports on PCCI contributing to the health kidney initiative




Mobile Health Times reports on PCCI contributing to the HHS health kidney initiative. Read below:

 

Parkland Center for Clinical Innovation Participating in the HHS ‘Advancing American Kidney Health’ Initiative

 

5 August 2019

In The News: Dallas Innovates covers PCCI’s involvement with the HHS kidney initiative




Read Dallas Innovates’ coverage of PCCI joining the HHS kidney initiative. Read below:

Parkland Center Joins Kidney Disease Initiative opens in a new window

30 July 2019

PCCI Participating in the HHS ‘Advancing American Kidney Health’ Initiative




DALLAS – Parkland Center for Clinical Innovation (PCCI), which improves healthcare for vulnerable populations using advanced data science and clinical experts, is contributing its capabilities to support elements of the “Advancing American Kidney Health Initiative” announced by the U.S. Department of Health and Human Services (HHS) earlier this month.

The HHS initiative’s aim is to improve the lives of the 37 million patients who suffer from chronic kidney disease and more than 726,000 who have end-stage renal disease. There are nearly 100,000 Americans waiting on the list to receive a kidney transplant. Kidney disease ranks as the ninth leading cause of death in America, costs Medicare $114 billion a year and represents one of the most significant expenses for the VA’s health programs.

PCCI is contributing to the initiative through two grants to the University of Texas Southwestern Medical Center’s Miquel Vazquez, MD. Specifically, PCCI will be applying its proficiency with advanced data science applied to electronic health records to aid at-risk patient identification and develop predictive modeling. This effort is in support of preventing and mitigating kidney disease, keeping patients out of hospitals, and helping find different ways to define and manage kidney disease.

“We are very proud to contribute PCCI’s unique combination of advanced data science and clinical expertise to this important initiative,” said PCCI’s President and CEO, Steve Miff, PhD. “This program, under Dr. Vazquez, the grant principle, is critical to millions of Americans who are suffering from kidney disease. We are excited that PCCI’s experience applying healthcare data in clinical settings with veterans and other groups prone to kidney disease is aiding the kidney health initiative.”

Members of PCCI’s advanced analytics and clinical teams are participating in the initiative’s research studies and work groups, helping advance the program’s goal of transforming the way kidney disease is prevented and treated.

About Parkland Center for Clinical Innovation

Parkland Center for Clinical Innovation (PCCI) is an independent, not-for-profit, healthcare intelligence organization affiliated with Parkland Health & Hospital System. PCCI focuses on creating connected communities through data science and cutting-edge technologies like machine learning. PCCI combines extensive clinical expertise with advanced analytics and artificial intelligence to enable the delivery of patient-centric precision medicine at the point of care.

29 July 2019

Deep Learning Model to Predict Pediatric Asthma Emergency Department Visits




Pediatric asthma is the most prevalent chronic childhood illness, afflicting about 6.2 million children in the United States. However, asthma could be better managed by identifying and avoiding triggers, educating about medications and proper disease management strategies.

Parkland Center for Clinical Innovation (PCCI) has been working with the Parkland Community Health Plan (PCHP) for the past four years to help them with timely identification of high risk asthma members in the pediatric population. We have deployed a logistic regression model on claims data that is the foundation for an innovative care redesign and text based patient engagement program that has show consistent cost savings and clinical outcomes improvement for PCHP members. You can learn more about this program here.

Thus, this issue for us is not merely an academic exercise. We realize that a predictive model with improved statistical performance can yield even better health outcomes for these families and improved cost savings for PCHP. Keeping that in mind, we have regularly looked for ways to continue to improve our model that is not just limited to retraining the model but also finding ways to improve data quality and bringing in additional data sets for workflow improvement. More recently, we decided to retrain the model using deep learning techniques — more specifically using an ANN.

Our deep learning model produced an AUC of 0.845 which was only slightly better than the AUC of the current logistic regression model at 0.842.

You can read about details of our work at arXiv here.

Healthcare has high expectations for the level of transparency from machine learning algorithms deployed in a clinical setting. Deep learning models with their relative lack of transparency are not always the best contender for those situations. However, if the improvement in performance of the model for relevant statistical measures is significant enough, then there can be a strong case for deployment of a deep learning model over say, a logistic regression model.

However, in this case, with the exact same data set and initial feature list, ANN model only produced slightly higher statistical classification power than the Lasso logistic regression. This is consistent with the results from some other published research that has compared logistic regression and ANN models in multiple medical data classification tasks. This study further confirmed that the Lasso logistic regression model developed by PCCI in 2015 could produce desirable statistical performance that is non-inferior to deep learning models which are more difficult to interpret. And in order for our predictive models to be deployed and effectively improve patient care, we need to work closely with clinicians to explain predictions in comprehensive and interpretable formats to build trust and transparency with stakeholders.

For future studies, blender algorithms would be tested against other singular models to achieve better statistical performances. We would explore the temporal relationships in claims data using other deep learning models, like Recurrent Neural Networks (RNN) and Long Short-Term Memory (LSTM).

Parkland Center for Clinical Innovation (PCCI) uses data, advanced analytics and Artificial Intelligence to help individuals lead healthier lives.

23 July 2019

PCCI’s Steve Miff Nominated for Dallas Business Journal’s Most Admired CEO Award




The Dallas Business Journal has announced that PCCI’s CEO, Steve Miff, PhD., has been nominated for its “2019 Most Admired CEO Award” in the healthcare category.

Dr. Miff joined PCCI as president and CEO in January 2017 and leads a pioneering organization that brings together top data scientists and healthcare experts to create programs supporting the health of vulnerable populations.

The Dallas Business Journal’s Most Admired CEO Awards honors the executives who inspire those around them, hold their employees, products and services in the highest regard, run their companies with integrity and are shining examples of how all companies should be run and managed.

Dr. Miff is a recognized national thought leader with more than 20 years of experience in healthcare analytics and consulting. He is a first generation American and has experienced first-hand many of the same challenges as the people PCCI supports in its community.

The Dallas Business Journal will honor its winners at a dinner on September 25, 2019. Rick Allen, CEO of Paragon Healthcare Inc., was the previous winner of the award in the healthcare category.

About Parkland Center for Clinical Innovation

Parkland Center for Clinical Innovation (PCCI) is an independent, not-for-profit, healthcare intelligence organization affiliated with Parkland Health & Hospital System. PCCI focuses on creating connected communities through data science and cutting-edge technologies like machine learning. PCCI combines extensive clinical expertise with advanced analytics and artificial intelligence to enable the delivery of patient-centric precision medicine at the point of care.

 

9 July 2019

PCCI’s Aida Somun Named to Malcolm Baldrige National Quality Award Board of Examiners for 2019




DALLAS – The Commerce Department’s National Institute of Standards and Technology (NIST) has named Aida Somun, Chief Operations Officers at Parkland Center for Clinical Innovation (PCCI opens in a new window) in Dallas, Texas, to the Board of Examiners for the 2019 MalcolmBaldrige National Quality Award. The Baldrige Award is the nation’s highest honor for organizational innovation and performance excellence.

Appointed by the NIST Director, examiners are responsible for reviewing and evaluating applications submitted for the Baldrige Award, as well as other assessment-related tasks. The examiner board is composed of more than 325 leading experts competitively selected from industry, professional, trade, education, healthcare and nonprofit (including government) organizations from across the United States.

Those selected meet the highest standards of qualification and peer recognition, demonstrating competencies related to customer focus, communication, ethics, action orientation, team building and analytical skills. All members of the board must take part in a nationally ranked leadership development course based on the Baldrige Excellence Framework and the scoring/evaluation processes for the Baldrige Award. They must also complete an independent review of a Baldrige Award application or other comparable examiner task.

Somun has 15 years of experience as a business leader known for driving profitable growth, cost savings and delivery. She ensures operational excellence through consistent contributions to bottom line efficiency, performance and process improvements. She is most passionate about leading and influencing strategic decision-making for operationalizing the right innovative programs focused on improving individual’s health, both physical as well as socio-economic.

Named after Malcolm Baldrige, the 26th Secretary of Commerce, the Baldrige Award was established by Congress in 1987. Awards may be given annually to organizations in each of six categories: manufacturing, service, small business, education, healthcare and nonprofit. The Award promotes innovation and excellence in organizational performance, recognizes the achievements and results of U.S. organizations, and publicizes successful performance strategies. Since the first group was recognized in 1988, 124 awards have been presented to 115 organizations (including eight repeat recipients).

NIST manages the Baldrige Award in close conjunction with the private sector.

The Baldrige Performance Excellence Program also offers the 2019–2020 BaldrigeExcellence Framework: Proven Leadership and Management Practices for High Performance, which includes the world-emulated Criteria for Performance Excellence;Baldrige Excellence Builder; Baldrige Cybersecurity Excellence Builder; nationally ranked leadership training; and the Baldrige Collaborative Assessment and other assessment tools.

###

 

About Parkland Center for Clinical Innovation

Parkland Center for Clinical Innovation (PCCI opens in a new window) is an independent, not-for-profit, healthcare intelligence organization affiliated with Parkland Health & Hospital System. PCCI opens in a new window focuses on creating connected communities through data science and cutting-edge technologies like machine learning. PCCI opens in a new window combines extensive clinical expertise with advanced analytics and artificial intelligence to enable the delivery of patient-centric precision medicine at the point of care.

27 June 2019

Centers for Medicare & Medicaid Services selects PCCI as a Prime awardee of the Network of Quality Improvement and Innovation Contractor




DALLAS The Centers for Medicare & Medicaid Services (CMS) has selected Parkland Center for Clinical Innovation (PCCI) as a Prime awardee of the Network of Quality Improvement and Innovation Contractor. This designation will allow NQIICs to bid on Task Orders over the next five years. As a Prime NQIIC awardee partnering with other Quality Improvement contractors under the new CMS Indefinite Delivery/Indefinite Quantity (IDIQ) contract mechanism to support quality improvement efforts, each NQIIC may serve as:

  • Quality Improvement Experts
  • Facilitators/change agents for healthcare transformation by achieving bold aims at a high value
  • Innovators of quality improvement

As a NQIIC awardee, PCCI has demonstrated healthcare quality improvement expertise. Services supported by some of the NQIIC awardees may include:

  • Provide direct technical assistance in specific areas of healthcare quality improvement (e.g., patient safety, opioid misuse, nursing home quality, etc.)
  • Seek and gain commitments from patients, providers and stakeholders to achieve aims
  • Use a Human Centered Design that involves teaming with patient and family members to improve healthcare processes and outcomes
  • Focused on helping providers and healthcare organizations to achieve quantitative results for improved outcomes, lower costs, better care, less provider burden, greater transparency and more
  • Supporting a diverse array of organizations and populations, including: rural providers, vulnerable beneficiaries, clinical practices, hospitals, nursing homes, dialysis facilities and more
  • Support providers in efficient use of Health Information Technology and interoperability
  • Serve as backbone organizations to form and engage Community Coalitions
  • Convene and support Learning and Action Networks (LANs).

About Parkland Center for Clinical Innovation

Parkland Center for Clinical Innovation (PCCI) is an independent, not-for-profit, healthcare intelligence organization affiliated with Parkland Health & Hospital System. PCCI focuses on creating connected communities through data science and cutting-edge technologies like machine learning. PCCI combines extensive clinical expertise with advanced analytics and artificial intelligence to enable the delivery of patient-centric precision medicine at the point of care.

19 June 2019

Parkland Center for Clinical Innovation Expands Opportunities for Women with Data Science and Technology Summer Internship Program




DALLAS – Parkland Center for Clinical Innovation (PCCI), improving healthcare in our communities with advanced analytics and artificial intelligence, recognizes the importance of a STEM education. Offering opportunities to women interested in data science is particularly crucial, which is the mission of PCCI’s summer internship program.

PCCI’s Women in Data Science and Technology Summer Internship, in collaboration with Southern Methodist University’s (SMU) Statistics Department, is one of the most prestigious internship programs in North Texas with a mission to expand opportunities for women in an industry that significantly lacks gender diversity.

The seven women participating in PCCI’s Women in Data Science and Technology Summer Internship program include high school, college and graduate students from Dallas Independent School District high schools, SMU’s Statistics Department as well as students from the University of Texas at Dallas and Creighton University.

The program’s interns will be immersed in PCCI’s daily work where they will directly experience the organization’s innovative healthcare and social determinants of health programs. The students will also have hands-on exposure to the practical applications of analytics, computing and data science.

“The Women in Data Science and Technology Summer Internship program is a rigorous and meaningful path that demonstrates to women what to expect and how to enter the technology market,” Steve Miff, PhD, President and CEO of PCCI. “Because of the important and valuable contributions from organizations such as SMU’s Statistics Department, we are able to place women side-by-side with clinical and data science experts where they can hone their programming and analytics skills within an atmosphere of mentorship and advancement.”

PCCI celebrates diversity and inclusion with a workforce that includes 54 percent women with 30 percent of its employees representing various ethnicities and communities from around the world. As an example of PCCI’s successful commitment to diversity, the Dallas Business Journal recently named Priyanka Kharat, PCCI’s Vice President, Data Engineering and Machine Learning, as a 2019 Women in Technology honoree.

PCCI’s Women in Data Science and Technology Summer Internship program is currently underway and will conclude in mid-August with a presentation program for their PCCI mentors showcasing the impact their projects are having on the Dallas community and Parkland Health & Hospital System.

About Parkland Center for Clinical Innovation

Parkland Center for Clinical Innovation (PCCI) is an independent, not-for-profit, healthcare intelligence organization affiliated with Parkland Health & Hospital System. PCCI focuses on creating connected communities through data science and cutting-edge technologies like machine learning. PCCI combines extensive clinical expertise with advanced analytics and artificial intelligence to enable the delivery of patient-centric precision medicine at the point of care.

 

###

Parkland Health & Hospital System, Department of Corporate Communications

5200 Harry Hines Blvd., Dallas TX 75235, 469-419-4400

www.parklandhospital.com

27 March 2019

PCCI names new Chief Funding and Innovation Officer




Brings decades of healthcare strategy, innovation management to organization

DALLAS – Leslie Wainwright, PhD has been named Chief Funding and Innovation Officer for the Parkland Center for Clinical Innovation (PCCI).

“We are very excited to welcome Dr. Wainwright to PCCI. Leslie’s experience in working with strategy leaders, innovation executives and philanthropic organizations will be instrumental in PCCI reaching its full potential of advancing artificial intelligence and addressing social determinants of health. Leslie will be integral to the organization as it continues to expand solutions to support healthier communities and a great asset to the PCCI leadership team,” said PCCI’s President and CEO, Steve Miff, PhD.

Dr. Wainwright brings 20 years of experience in healthcare strategy and innovation management to PCCI. She comes from RTI International, a global nonprofit research institution, where she led the Innovation Advisor Health Sector Practice and worked with health systems and technology companies to accelerate the development of high-impact innovations. Through executive roles at Sg2 and AVIA, Dr. Wainwright has worked with some of the largest and most influential organizations in healthcare and has assisted leadership teams structure strategically-aligned innovation programs that are economically self-sustainable. She is a frequent national and international speaker on enabling technologies, disruptive innovation and emerging healthcare business models.

Dr. Wainwright will focus her efforts on expanding PCCI’s innovation research and development network across the Dallas-Fort Worth metroplex and nationally. In addition, she will work with organizations and communities outside of Dallas to accelerate and broaden the impact and development of new and innovative solutions. With deep roots in Chicago and established national relationships she hopes to tap into the same philanthropic and community spirit that has benefitted PCCI and the healthcare community so greatly in Dallas. Dr. Wainwright will divide her time between PCCI’s Dallas office and Chicago.

About PCCI
PCCI is an independent, not-for-profit, healthcare intelligence organization affiliated with Parkland Health & Hospital System. PCCI focuses on creating connected communities through data science and cutting-edge technologies like machine learning. PCCI combines extensive clinical expertise with advanced analytics and artificial intelligence to enable the delivery of patient-centric precision medicine at the point of care.

Contact
PCCI
Esther Olsen
214-590-4446
Esther.olsen@pccinnovation.org